{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:48:14Z","timestamp":1780393694635,"version":"3.54.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Blair Foundation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>N-terminal pro B-type natriuretic peptide (NT-proBNP), a cardiac disease biomarker, has been demonstrated to be a strong independent predictor of cardiovascular events in patients without heart failure. Patients with peripheral arterial disease (PAD) are at high risk of cardiovascular events and death. In this study, we investigated levels of NT-proBNP in patients with PAD compared to non-PAD controls. A total of 355 patients were recruited from outpatient clinics at a tertiary care hospital network. Plasma NT-proBNP levels were quantified using protein multiplex. There were 279 patients with both clinical and diagnostic features of PAD and 76 control patients without PAD (non-PAD cohort). Compared with non-PAD patients, median (IQR) NT-proBNP levels in PAD patients were significantly higher (225 ng\/L (120\u2013363) <jats:italic>vs<\/jats:italic> 285 ng\/L (188\u2013425), p- value = 0.001, respectively). Regression analysis demonstrated that NT-proBNP remained significantly higher in patients with PAD relative to non-PAD despite adjusting for age, sex, hypercholesterolemia, smoking and hypertension [odds ratio = 1.28 (1.07\u20131.54), p-value &lt;0.05]. Subgroup analysis showed elevated NT-proBNP levels in patients with PAD regardless of prior history of CHF, CAD, diabetes and hypercholesteremia (p-value &lt;0.05). Finally, spearmen\u2019s correlation analysis demonstrated a negative correlation between NT-proBNP and ABI (\u03c1 = -0.242; p-value &lt; 0.001). In conclusion, our data shows that patients with PAD in an ambulatory care setting have elevated levels of NT-proBNP compared to non-PAD patients in the absence of cardiac symptoms.<\/jats:p>","DOI":"10.1371\/journal.pone.0253792","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T17:39:04Z","timestamp":1626889144000},"page":"e0253792","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease"],"prefix":"10.1371","volume":"16","author":[{"given":"Bader","family":"Alsuwailem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Zamzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzammil H.","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Wheatcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"de Mestral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Harlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawand","family":"Abdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0893-9920","authenticated-orcid":true,"given":"Mohammad","family":"Qadura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"issue":"9901","key":"pone.0253792.ref001","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"FGR Fowkes","year":"2013","journal-title":"The Lancet"},{"issue":"4","key":"pone.0253792.ref002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amepre.2006.12.010","article-title":"Ethnic-specific prevalence of peripheral arterial disease in the United States","volume":"32","author":"MA Allison","year":"2007","journal-title":"American journal of preventive medicine"},{"issue":"9","key":"pone.0253792.ref003","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"MH Criqui","year":"2015","journal-title":"Circulation research"},{"issue":"21","key":"pone.0253792.ref004","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/01.CIR.0000128517.52533.DB","article-title":"Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association","volume":"109","author":"DP Faxon","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"pone.0253792.ref005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","article-title":"Peripheral artery disease: epidemiology and global perspectives","volume":"14","author":"FGR Fowkes","year":"2017","journal-title":"Nature Reviews Cardiology"},{"issue":"4","key":"pone.0253792.ref006","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/1358863X13493825","article-title":"Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.","volume":"18","author":"SM Grenon","year":"2013","journal-title":"Vascular medicine"},{"issue":"3","key":"pone.0253792.ref007","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5694\/j.1326-5377.2004.tb06206.x","article-title":"Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications","volume":"181","author":"PE Norman","year":"2004","journal-title":"Medical Journal of Australia"},{"key":"pone.0253792.ref008","article-title":"The ankle-brachial index as a biomarker of cardiovascular risk: it\u2019s not just about the legs.","author":"TS Perlstein","year":"2009","journal-title":"Am Heart Assoc"},{"issue":"12","key":"pone.0253792.ref009","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.6061\/clinics\/2013(12)02","article-title":"Ankle-brachial index as a predictor of coronary disease events in elderly patients submitted to coronary angiography.","volume":"68","author":"ED Papa","year":"2013","journal-title":"Clinics"},{"issue":"3","key":"pone.0253792.ref010","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2337\/diacare.29.03.06.dc05-1637","article-title":"Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study","volume":"29","author":"SH Wild","year":"2006","journal-title":"Diabetes Care"},{"issue":"4","key":"pone.0253792.ref011","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11606-006-5042-4","article-title":"Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease","volume":"12","author":"MM McDermott","year":"1997","journal-title":"Journal of general internal medicine"},{"issue":"6","key":"pone.0253792.ref012","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/hrt.2005.071233","article-title":"Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine.","volume":"92","author":"M Weber","year":"2006","journal-title":"Heart"},{"issue":"19","key":"pone.0253792.ref013","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0195-668X(03)00476-7","article-title":"Clinical applications of B-type natriuretic peptide (BNP) testing.","volume":"24","author":"M Cowie","year":"2003","journal-title":"European heart journal"},{"issue":"5","key":"pone.0253792.ref014","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/endo.132.5.8477647","article-title":"Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching","volume":"132","author":"P Kinnunen","year":"1993","journal-title":"Endocrinology"},{"issue":"4","key":"pone.0253792.ref015","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2005.11.030","article-title":"B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure","volume":"47","author":"Y Iwanaga","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"pone.0253792.ref016","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1373\/clinchem.2006.069575","article-title":"Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.","volume":"52","author":"S Masson","year":"2006","journal-title":"Clinical chemistry"},{"issue":"10","key":"pone.0253792.ref017","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/ejhf.414","article-title":"Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs","volume":"17","author":"S Sanders\u2010van Wijk","year":"2015","journal-title":"reduced left ventricular ejection fraction. European journal of heart failure"},{"issue":"3","key":"pone.0253792.ref018","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/CIRCHEARTFAILURE.110.958199","article-title":"Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure. Circulation","volume":"4","author":"MR Zile","year":"2011","journal-title":"Heart Failure"},{"key":"pone.0253792.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2423(05)40001-3","article-title":"BNP as a biomarker in heart disease","volume":"40","author":"O Vuolteenaho","year":"2005","journal-title":"Advances in clinical chemistry"},{"issue":"8","key":"pone.0253792.ref020","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"18","author":"P Ponikowski","year":"2016","journal-title":"Eur J Heart Fail."},{"issue":"8","key":"pone.0253792.ref021","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.","volume":"95","author":"JL Januzzi","year":"2005","journal-title":"The American journal of cardiology"},{"issue":"2","key":"pone.0253792.ref022","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.297.2.169","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.","volume":"297","author":"K Bibbins-Domingo","year":"2007","journal-title":"Jama"},{"issue":"3","key":"pone.0253792.ref023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2007.03.038","article-title":"Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial","volume":"50","author":"T Omland","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"pone.0253792.ref024","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jacc.2005.06.085","article-title":"Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease","volume":"47","author":"M Richards","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"pone.0253792.ref025","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.3390\/jcm9092843","article-title":"Fatty Acid Binding Protein 4\u2014A Circulating Protein Associated with Peripheral Arterial Disease in Diabetic Patients","volume":"9","author":"A Zamzam","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"pone.0253792.ref026","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","article-title":"The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI).","volume":"59","author":"JL Mills","year":"2014","journal-title":"Journal of vascular surgery"},{"issue":"7352","key":"pone.0253792.ref027","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/bmj.324.7352.1498","article-title":"Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations","volume":"324","author":"F Hobbs","year":"2002","journal-title":"Bmj"},{"issue":"13","key":"pone.0253792.ref028","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/01.CIR.0000143059.68996.A7","article-title":"Prognostic impact of plasma N-terminal pro\u2013brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.","volume":"110","author":"F Hartmann","year":"2004","journal-title":"Circulation"},{"issue":"19","key":"pone.0253792.ref029","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"FP Brouwers","year":"2013","journal-title":"European heart journal"},{"issue":"8","key":"pone.0253792.ref030","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2337\/diacare.27.8.1929","article-title":"Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease","volume":"27","author":"M Magnusson","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"pone.0253792.ref031","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5114\/aoms.2015.57001","article-title":"Correlation between B type natriuretic peptide and metabolic risk factors.","volume":"12","author":"W-H Zhu","year":"2016","journal-title":"Archives of medical science: AMS."},{"issue":"2","key":"pone.0253792.ref032","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5114\/aoms.2011.22075","article-title":"Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome.","volume":"7","author":"Y Bao","year":"2011","journal-title":"Archives of medical science: AMS."},{"issue":"19","key":"pone.0253792.ref033","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/eurheartj\/ehp355","article-title":"Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry","volume":"30","author":"MJ Alberts","year":"2009","journal-title":"European heart journal"},{"issue":"7","key":"pone.0253792.ref034","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1161\/CIRCULATIONAHA.105.593442","article-title":"Peripheral arterial disease: morbidity and mortality implications","volume":"114","author":"BA Golomb","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"pone.0253792.ref035","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1525-1497.2002.20307.x","article-title":"Atherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician survey.","volume":"17","author":"M Mc Grae McDermott","year":"2002","journal-title":"Journal of general internal medicine"},{"issue":"4","key":"pone.0253792.ref036","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/qjmed\/92.4.219","article-title":"Cholesterol in peripheral vascular disease\u2014a suitable case for treatment?","volume":"92","author":"A Clark","year":"1999","journal-title":"Qjm"},{"issue":"15","key":"pone.0253792.ref037","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/01.CIR.0000035649.39669.CE","article-title":"Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2).","volume":"106","author":"D Mukherjee","year":"2002","journal-title":"Circulation"},{"key":"pone.0253792.ref038","doi-asserted-by":"crossref","first-page":"100553","DOI":"10.1016\/j.ijcha.2020.100553","article-title":"NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study.","volume":"29","author":"H Rudolf","year":"2020","journal-title":"IJC Heart & Vasculature."},{"issue":"3","key":"pone.0253792.ref039","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1358836X9800300311","article-title":"The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease","volume":"3","author":"MH Criqui","year":"1998","journal-title":"Vascular Medicine"},{"issue":"7","key":"pone.0253792.ref040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"TJ Wang","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"pone.0253792.ref041","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1373\/clinchem.2006.080234","article-title":"Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure.","volume":"53","author":"M Emdin","year":"2007","journal-title":"Clin Chem"},{"issue":"1\u20132","key":"pone.0253792.ref042","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cca.2008.10.011","article-title":"Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP","volume":"400","author":"C Prontera","year":"2009","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"issue":"18","key":"pone.0253792.ref043","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1053\/euhj.1999.2045","article-title":"Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunction","volume":"21","author":"S Talwar","year":"2000","journal-title":"European heart journal"},{"issue":"1","key":"pone.0253792.ref044","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/cclm-2020-0310","article-title":"Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers","volume":"59","author":"A Clerico","journal-title":"Clinical chemistry and laboratory medicine"},{"issue":"41","key":"pone.0253792.ref045","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1093\/eurheartj\/ehaa083","article-title":"High-sensitivity cardiac troponin assays for cardiovascular risk stratification in the general population","volume":"41","author":"D Farmakis","year":"2020","journal-title":"Eur Heart J"},{"issue":"4","key":"pone.0253792.ref046","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2174\/157340308786349499","article-title":"Natriuretic peptide testing in primary care.","volume":"4","author":"SU Rehman","year":"2008","journal-title":"Current Cardiology Reviews"},{"issue":"2","key":"pone.0253792.ref047","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jacc.2013.08.1630","article-title":"The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis","volume":"63","author":"RN Rodseth","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"pone.0253792.ref048","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/heart.89.7.745","article-title":"The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population","volume":"89","author":"I Raymond","year":"2003","journal-title":"Heart"},{"issue":"5","key":"pone.0253792.ref049","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","article-title":"Plasma brain natriuretic peptide concentration: impact of age and gender","volume":"40","author":"MM Redfield","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"pone.0253792.ref050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0002-9149(02)02464-5","article-title":"Impact of age and sex on plasma natriuretic peptide levels in healthy adults","volume":"90","author":"TJ Wang","year":"2002","journal-title":"The American journal of cardiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0253792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T17:39:43Z","timestamp":1626889183000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0253792"}},"subtitle":[],"editor":[{"given":"Vincenzo","family":"Lionetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0253792","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]}}}